Drug profile · INN
sugemalimab
CEJEMLY
- Patents linked
- 0
- News articles
- 0
Quick answer
sugemalimab (CEJEMLY) is an FDA-listed pharmaceutical active ingredient.
Key facts
INN sugemalimab
Brand CEJEMLY
ATC code L01FF11
Frequently asked questions
What is sugemalimab?
sugemalimab (CEJEMLY) is an FDA-listed pharmaceutical active ingredient.
What is the brand name for sugemalimab?
CEJEMLY is a marketed brand name for sugemalimab. Check FDA Drugs@FDA for the current US label holder and prescribing information.